Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis

Pfizer

Status: Completed

Conditions: Ankylosing Spondylitis

Treatments: Drug: Etanercept

Study type: Observational

Funder types: Industry

Identifiers

NCT00544557

0881X1-4463

B1801087 (Other Identifier)

Details and patient eligibility

About

This study aims to provide a holistic assessment of patients receiving etanercept in a real-world setting.

Full description

Non-interventional study: subjects to be selected according to the usual clinical practice of their physician

Enrollment: 1,715 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of ankylosing spondylitis (AS)

Exclusion criteria

• Hypersensitivity to etanercept
• Active infection including chronic or localised infection
• Sepsis or risk of sepsis

Trial design

1,715 participants in 1 patient group

Patients with Ankylosing Spondylitis

Treatment:

Drug: Etanercept